0001645113-21-000069.txt : 20210528
0001645113-21-000069.hdr.sgml : 20210528
20210528163612
ACCESSION NUMBER: 0001645113-21-000069
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20210527
FILED AS OF DATE: 20210528
DATE AS OF CHANGE: 20210528
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Benaim Ely
CENTRAL INDEX KEY: 0001632237
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37565
FILM NUMBER: 21980905
MAIL ADDRESS:
STREET 1: C/O REXAHN PHARMACEUTICALS, INC.
STREET 2: 15245 SHADY GROVE ROAD, SUITE 455
CITY: ROCKVILLE
STATE: MD
ZIP: 20850
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: NovoCure Ltd
CENTRAL INDEX KEY: 0001645113
STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
IRS NUMBER: 000000000
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: NO. 4 THE FORUM
STREET 2: GRENVILLE STREET
CITY: ST. HELIER
STATE: Y9
ZIP: JE2 4UF
BUSINESS PHONE: 44 (0)15 3475 6700
MAIL ADDRESS:
STREET 1: NO. 4 THE FORUM
STREET 2: GRENVILLE STREET
CITY: ST. HELIER
STATE: Y9
ZIP: JE2 4UF
FORMER COMPANY:
FORMER CONFORMED NAME: Novocure Ltd
DATE OF NAME CHANGE: 20150615
4
1
wf-form4_162223413522679.xml
FORM 4
X0306
4
2021-05-27
0
0001645113
NovoCure Ltd
NVCR
0001632237
Benaim Ely
C/O NOVOCURE INC.,
20 VALLEY STREAM PARKWAY, SUITE 300
MALVERN
PA
19355
0
1
0
0
Chief Medical Officer
Ordinary Shares
2021-05-27
4
M
0
1833
47.56
A
30887
D
Ordinary Shares
2021-05-27
4
S
0
1833
200
D
29054
D
Options to Buy Ordinary Shares
47.56
2021-05-27
4
M
0
1833
0
D
2029-05-07
Ordinary Shares
1833.0
7332
D
Transaction was made pursuant to a Rule 10b-5-1 trading plan adopted by Dr. Benaim.
Fully vested as of the date hereof.
By: /s/ Steven Robbins, Attorney in Fact for Ely Benaim
2021-05-28